Mental Health DailyResearch. Evidence. Perspective.Published research on mechanism of action.
Vraylar (Cariprazine) was approved by the FDA on September 17, 2015 for the treatment of schizophrenia and mania associated with bipolar disorder. In clinical trials, the drug was referenced…
Read articleRexulti (Brexpiprazole) is a drug that was approved July 10, 2015 for the treatment of schizophrenia and as an adjunctive option for major depressive disorder. In clinical trials it was refe…
Read articleDepression is a growing epidemic that affects the lives of nearly 15 million Americans. The number of individuals diagnosed with depression will continue to grow as a result of population gr…
Read articleA ketogenic diet involves consumption of foods with high fat (80%), moderate protein (15%), and low carbohydrates (5%). Consistent intake of high fat, moderate protein foods, with simultaneo…
Read articleL-Theanine is considered an amino acid analogue of both L-glutamate and L-glutamine, and is commonly derived from various species of plants. L-theanine is perhaps best known for being presen…
Read articleGinkgo Biloba is a highly popular tree native to China that is often cultivated for use as both a food source and dietary supplement. Some fossil evidence suggests that Ginkgo has been utili…
Read articleRhodiola rosea is a perennial plant in the Crassulaceae family that grows in cold, mountainous regions and/or on cliffs. Rhodiola is most commonly extracted from regions such as the Arctic, …
Read article